{"slideshow_credits": null, "snippet": "When a drug works, patients and insurance companies should pay the full price of the drug. When it doesn\u2019t, they should pay nothing.", "abstract": "Op-Ed article by Kadmon Corporation founder Samuel D Waksal proposes a system in which health care providers and patients would only pay for drugs if they are effective; holds method would cut costs and create incentives for drug developers; points out a pay-for-response model would also fuel scientific innovation.", "section_name": "Opinion", "print_page": "27", "document_type": "article", "byline": {"person": [{"firstname": "Samuel", "role": "reported", "rank": 1, "organization": ""}], "original": "By SAMUEL D. WAKSAL", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/03/07/opinion/pay-only-for-drugs-that-help-you.html", "lead_paragraph": "When a drug works, patients and insurance companies should pay the full price of the drug. When it doesn\u2019t, they should pay nothing.", "headline": {"seo": "Pay Only for Drugs That Help You", "main": "Pay Only for Drugs That Help You", "print_headline": "Pay Only for Drugs That Help You", "content_kicker": "Op-Ed Contributor", "kicker": "Op-Ed Contributor"}, "_id": "53f4551c38f0d857ea2d0eca", "word_count": "825", "multimedia": [], "pub_date": "2012-03-07T00:00:00Z", "source": "The New York Times", "news_desk": "OpEd", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Health Insurance and Managed Care", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Genetics and Heredity", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Biotechnology", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Cancer", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Reform and Reorganization", "name": "subject", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "Op-Ed"}